Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015067 · ClinicalTrials.gov registry record · Phase 1
Cocaine-Methylphendidate Interaction Study - 4
A Phase 1 study of Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT00015067: Completed Phase 1 study of Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
NCT00015067 is a Phase 1 study of Cocaine-Related Disorders that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 8 participants, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015067, a Phase 1 study of Cocaine-Related Disorders, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to attempt to identify possible dangerous interactions between cocaine and methylphenidate (MPD). Additional objectives are to determine: a) if MPD reduces the craving and high for cocaine; b) if there are pharmacokinetic and pharmacodynamic interactions between cocaine and MPD; and c) the relationship between cocaine and benzoylecgonine (BE) levels in plasma and BE levels in urine.
Conditions Studied
Interventions
- DRUG Methylphenidate
Study Locations (1)
Ohio
- Cincinnati MDRU - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 1997-12 |
| Phase | Phase 1 |
What the finished NCT00015067 record still lists
NCT00015067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Methylphenidate is the first listed.
NCT00015067 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00015067 about?
NCT00015067 is a clinical study titled "Cocaine-Methylphendidate Interaction Study - 4". The purpose of this study is to attempt to identify possible dangerous interactions between cocaine and methylphenidate (MPD). Additional objectives are to determine: a) if MPD reduces the craving and high for cocaine; b) if there are pharmacokinetic and pharmacodynamic interactions between cocaine ...
What is the current status of trial NCT00015067?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 1997-12.
What conditions does trial NCT00015067 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders.
What interventions are being tested in trial NCT00015067?
The interventions under investigation include: Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00015067?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015067 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00015067's enrollment target sits among peer trials
8 15th of 15 the lowest of 15 other Cocaine-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
COMPLETED · Phase 1
-
Cocaethylene as a Treatment for Cocaine Dependence - 1
COMPLETED · Phase 1
-
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
COMPLETED · Phase 1
-
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
COMPLETED · Phase 1
-
Prepulse Inhibition of Startle in Cocaine Dependence - 7
COMPLETED · Phase 1
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia